Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00314808 · ClinicalTrials.gov registry record · Phase 1
A Pilot Study of Dronabinol for Adult Patients With Primary Gliomas
A Phase 1 study, sponsored by Duke University.
- Completed
- Registry status
- Phase 1
- Development phase
- 33
- Enrollment target
NCT00314808 is a Phase 1 study that has completed, run by Duke University. The registered enrollment target is 33 participants.
The verdict
NCT00314808, a Phase 1 study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 33 participants
- Enrollment target
Study Summary
This study seeks to define the tolerability and safety associated with the administration of Dronabinol in the treatment of adults with nausea, vomiting and appetite loss in patients with primary gliomas who are undergoing chemotherapy treatment. The study will also describe the effect of Dronabinol on the quality of life in terms of nausea, vomiting and anorexia in this patient group.
Interventions
- DRUG Dronabinol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2006-04 |
| Est. Completion | 2012-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00314808
The ClinicalTrials.gov registry entry for NCT00314808 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dronabinol is the first listed.
NCT00314808 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00314808 about?
NCT00314808 is a clinical study titled "A Pilot Study of Dronabinol for Adult Patients With Primary Gliomas". This study seeks to define the tolerability and safety associated with the administration of Dronabinol in the treatment of adults with nausea, vomiting and appetite loss in patients with primary gliomas who are undergoing chemotherapy treatment. The study will also describe the effect of Dronabinol...
What is the current status of trial NCT00314808?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 33 participants. The study started on 2006-04. Estimated completion is 2012-04.
What interventions are being tested in trial NCT00314808?
The interventions under investigation include: Dronabinol (DRUG).
Who is sponsoring clinical trial NCT00314808?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.